Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513331 · ClinicalTrials.gov registry record
Barrett's Esophagus & Gastroesophageal Reflux Disease
A clinical trial, sponsored by Valley Health System.
- Completed
- Registry status
- 125
- Enrollment target
NCT00513331: Completed study, sponsored by Valley Health System.
NCT00513331 is a clinical trial that has completed, run by Valley Health System. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00513331 has completed, sponsored by Valley Health System.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
This is a study of Barrett's Esophagus (BE) and Gastroesophageal Reflux Disease (GERD). It aims to look at the long term efficacy of evidence-based cutting edge diagnostic and therapeutic algorithms and techniques such as radiofrequency ablation, endoscopic mucosal resection and surveillance endoscopy with biopsy. Additionally, biological analyses will be performed in hopes of identifying biomarkers associated with the progression of BE to esophageal cancer.
Interventions
- PROCEDURE Endoscopy
- PROCEDURE Radiofrequency ablation protocol
- PROCEDURE Endoscopic mucosal resection protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2007-07 |
| Est. Completion | 2013-12 |
What the finished NCT00513331 record still lists
NCT00513331 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Endoscopy is the first listed.
NCT00513331 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00513331 about?
NCT00513331 is a clinical study titled "Barrett's Esophagus & Gastroesophageal Reflux Disease". This is a study of Barrett's Esophagus (BE) and Gastroesophageal Reflux Disease (GERD). It aims to look at the long term efficacy of evidence-based cutting edge diagnostic and therapeutic algorithms and techniques such as radiofrequency ablation, endoscopic mucosal resection and surveillance endosco...
What is the current status of trial NCT00513331?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2007-07. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00513331?
The interventions under investigation include: Endoscopy (PROCEDURE), Radiofrequency ablation protocol (PROCEDURE), Endoscopic mucosal resection protocol (PROCEDURE).
Who is sponsoring clinical trial NCT00513331?
This trial is sponsored by Valley Health System, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia